A Friends of Cancer Research white paper argues that the use of pre-clinical, dosing and manufacturing data from Gilead Sciences, Inc./Kite Pharma’s Yescarta CAR-T therapy to support approval of the follow-on Tecartus provides a model for the US FDA to use in streamlining iterative product development of cellular therapies. “Yescarta and Tecartus provide an example of extrapolation in…
Marlene Malek — a devoted Marymount University alumna, long-time member of its Board of Trustees and a dedicated supporter of the institution — received the prestigious Lincoln Medal at the Ford’s Theatre’s annual gala on June 11. It’s awarded by the Ford’s Theatre Society to individuals who exhibit an impressive body of professional work, accomplishments or personal attributes that…
The Food and Drug Administration has launched a pilot program for oncology drug products used with certain in vitro diagnostic tests to help physicians choose appropriate cancer treatments, according to the FDA Tuesday. The voluntary pilot program will allow the FDA to request performance information for the tests used to enroll patients into the clinical…
WHAM LAUNCHES #3NOT30 CAMPAIGN TO CALL FOR ACCELERATING AND INVESTING IN THE HEALTH OF WOMEN IN THE NEXT THREE YEARS Women’s Health Access Matters (WHAM) Announces a Commemoration in Washington D.C., Featuring Hon. Barbara Mikulski, Hon. Connie Morella, Dr. Vivian Pinn, and Current Legislators Supporting Greater Inclusion of Women in Research and Clinical Trials WASHINGTON, June 15, 2023 /PRNewswire/ — Speaker Emerita Nancy Pelosi kicked off a celebration of the 30th Anniversary of the NIH Revitalization Act of 1993 to acknowledge…
When COVID lockdowns began in early 2020, millions of people went without cancer screenings they otherwise would have gotten. The full cost of this lapse in cancer surveillance is only starting to come into focus, but early data suggests it could be immense. And physicians fear this screening gap could continue getting wider in the…
U.S. must maintain global leadership in science, technology, and medicine Discovery and innovation are sewn into our nation’s fabric. Many of humanity’s greatest accomplishments of the past century were conceived by Americans and supported by government and private-sector investment in the United States. In the realm of health and well-being, our most prolific federal accelerator of lifesaving discovery has…
U.S. must maintain global leadership in science, technology, and medicine Discovery and innovation are sewn into our nation’s fabric. Many of humanity’s greatest accomplishments of the past century were conceived by Americans and supported by government and private-sector investment in the United States. In the realm of health and well-being, our most prolific federal accelerator of lifesaving discovery has…
More than 50 years since the United States declared a war on cancer, the disease remains the second leading cause of death among Americans. According to federal data, cancer killed nearly 608,000 Americans in 2022, behind only heart disease. Yet researchers, oncologists and advocates say the scientific and political landscapes today are dramatically different than…
The Food and Drug Administration is moving to regulate more closely a widely used class of tests that labs run to detect cancer, measure cholesterol and look for other health issues, people familiar with the agency’s deliberations said. The agency is drafting a proposal to help ensure the tests work as intended and are accurate, according to the people. The…
At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more. Featured Fred Hutch presentations and poster sessions are listed below; for a…
